| Dai Xiangkun,Cai Boning,Ge Ruigang,et al.Dosimetric comparison of helical tomotherapy and volume-modulated arc therapy for upper thoracic esophageal carcinoma[J].Chinese Journal of Radiological Medicine and Protection,2016,36(1):58-62 |
| Dosimetric comparison of helical tomotherapy and volume-modulated arc therapy for upper thoracic esophageal carcinoma |
| Received:August 18, 2015 |
| DOI：10.3760/cma.j.issn.0254-5098.2016.01.011 |
| KeyWords:Esophageal neoplasms Helical tomotherapy Volume-modulated arc therapy Dosimetry |
| FundProject: |
| Author Name | Affiliation | | Dai Xiangkun | Department of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China | | Cai Boning | Department of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China | | Ge Ruigang | Department of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China | | Wang Xiaoshen | Department of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China | | Wang Yunlai | Department of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China |
|
| Hits: 3628 |
| Download times: 2896 |
| Abstract:: |
| Objective To compare the dosimetric differences between helical tomotherapy (HT) and volume-modulated arc therapy (VMAT) in the treatment of upper thoracic esophageal carcinoma (UTEC). Methods A total of 10 patients with UTEC were randomly selected. HT plan and double-arc VMAT plan were designed and optimized for each patient. The prescription dose was 50 Gy/30 fractions for gross target volume (GTV), 66 Gy/30 fractions for planned target volume (PTV). The dose distribution and conformal index (CI), homogeneity index (HI) of target volume, the D1%, D5%, D95%, D99%, and dose of organ at risk (OAR) were analyzed by using the dose volume histogram (DVH). The monitor units and delivery time were also evaluated. Results For GTV and PTV, the D99% of HT plans were slightly higher than those of VMAT plans (t=4.476, 3.756, P<0.05), but no significant differences in D1%, D5%, D95%, HI and CI (P>0.05) were found. The V10, V15, V20 and mean lung dose (MLD) to the total-lung of HT plans were all significantly lower than those of VMAT plans (t=-3.369, -4.824, -4.869, -3.657, P<0.05). There were no significant differences for V5, V30 and Dmax of cord (P>0.05). The monitor units and delivery time of VMAT plans were significantly lower than those of HT plans (t=13.970, 7.982, P<0.05). Conclusions Both HT and VMAT are appropriate for esophageal cancer radiotherapy. HT significantly reduces the radiation dose of the total-lung, while VMAT has obvious advantages in efficiency. |
| HTML View Full Text View/Add Comment Download reader |
| Close |
|
|
|
